Document is current
Any future updates will be listed below
-
Authors
Miraki-Moud, Farideh
Ariza-McNaughton, Linda
KoKo, Thinzar
Othman, Jad
Stronge, Randal
de Bono, Johann
Russell, Nigel
Thomas, Ian https://orcid.org/0000-0002-8395-8075
Gilkes, Amanda https://orcid.org/0009-0006-2236-8852
Burnett, Alan https://orcid.org/0000-0003-1734-5817
Santiago, Leandro Rodrigues
Cafferty, Fay https://orcid.org/0000-0002-0973-660X
Taussig, Leo
Thornhill, Allan
O’Connor, Simon
Bonnet, Dominique https://orcid.org/0000-0002-4735-5226
Taussig, David C. https://orcid.org/0000-0002-9621-0146
-
Funding
Funding for this research was provided by:
Cancer Research UK (C15966/A24375, C26822, A16484, CRUK/08/025, A29806)
Bayer PLC NIHR BRC Grant code A153
- License Information
-
More Information
Article History
Received: 7 February 2025
Revised: 18 July 2025
Accepted: 27 August 2025
First Online: 11 September 2025
Competing interests
: Investigator initiated grant funding from Bayer to DCT.
